GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Global Health Clinics MJRX.CN · CAD

Health Care · Canadian Securities Exchange · 🇨🇦 Canada

Compare

0.40

—

Close of 4 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Global Health Clinics

Its shares trade on Canadian Securities Exchange under the ticker MJRX.CN. It has been listed since 16 August 2013. In the fiscal year to 31 July 2025, it reported revenue of C$47,771 and a net loss of C$1.3m. At that date it held total assets of C$66,145 and shareholders' equity of −C$4.5m.

Global Health Clinics Ltd. engages in the cannabis industry. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2013-08-16. The firm operates medical clinics, which guide patients through the process of becoming legal users of marijuana. The firm is also engaged in the development of psilocybin products for research and potentially usage for pharmaceutical purposes. The firm operates through two segments: medical clinics for legal user of marijuana, and psilocybin development. The Company’s subsidiaries include 2770914 Ontario Inc., 2756407 Ontario Ltd., Anytime Health Corp., MCRCI Medicinal Cannabis Resource Centre Inc. and Patient Access Pavilions Ltd.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
16 Aug 2013

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Global Health Clinics Ltd. operates 27 medical clinics in Canada for legal marijuana users.
  • The company develops psilocybin products for pharmaceutical research and potential medical use.
  • Subsidiaries include 2770914 Ontario Inc. and Patient Access Pavilions Ltd. for clinic operations.

Weaknesses

  • The firm's medical clinics segment is limited to Canada's legal marijuana market.
  • Psilocybin development faces regulatory hurdles in pharmaceutical applications.
  • The company's IPO in 2013 may limit recent capital for expansion.

Opportunities

  • Expanding psilocybin research could lead to new pharmaceutical products in Health Care.
  • Growing legal cannabis market in Canada offers potential for clinic network growth.
  • New partnerships with research institutions could accelerate psilocybin development.

Threats

  • Regulatory changes in Canada's cannabis industry could impact clinic operations.
  • Competition from other cannabis clinics may reduce market share in Canada.
  • Psilocybin research faces potential delays due to strict pharmaceutical regulations.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.